ArticlePrzeglad menopauzalny = Menopause review2023
The influence of SARS-CoV-2 infection on the quality of life of women who reach menopause.
Article in Przeglad menopauzalny = Menopause review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: At the time of the COVID-19 pandemic, providing adequate medical care in all its aspects, including the care of women with menopause and keeping social distance, was a challenge. Menopause results in a lower level of oestrogens and progesterone, which is the cause of lower immunological response and may result in more people being ill with COVID-19. The aim of the research was to evaluate the correlation between being sick with COVID-19 and the quality of life of women with menopause. Material and methods: The research was done in a group of 249 women with menopause. The criteria deciding about inclusion into the group were as follows: female gender, age 40-65 years, time after infection with SARS-CoV-2 virus 14-30 days, no hospitalization, and diagnosis of SARS-CoV-2 virus infection by means of anti-gene test. A propriety survey was used as well as medical documents analysis and a questionnaire with standardized WHOQOL-BREF. SPSS Statistics 27.0 program was used for statistical analysis. In all calculations Results: While evaluating the quality of life in the case of women after suffering from COVID-19 caused by the SARS-CoV-2 virus, no statistically significant difference was observed. The correlation between the level of satisfaction with one's health and suffering from SARS-CoV-2 was within the range of α = 0.1, with a significance level Conclusions: No statistically significant correlation was noted between the quality of life of women with menopause after SARS-CoV-2 and women who did not suffer from it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.